Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1968 1
1969 1
1970 2
1974 1
1975 1
1976 1
1977 1
1981 1
1982 2
1983 1
1985 1
1987 2
1988 1
1990 1
1992 1
1993 2
1994 1
1995 2
1996 4
1997 5
1999 1
2000 2
2002 1
2005 2
2006 2
2007 3
2008 2
2010 1
2012 5
2013 1
2014 7
2016 2
2017 6
2018 4
2019 4
2020 5
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Results by year
Filters applied: . Clear all
Page 1
Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area.
Shimura S, Watari H, Komatsu M, Kuchibiro T, Fukuda S, Nishio H, Kita M, Kida K, Oohama M, Toda H, Nishio M, Nishi I, Kimura K, Sawa K, Fukuda N, Kofuku T, Nakai I, Niki M, Ono T, Nakamura T, Wada Y. Shimura S, et al. Among authors: sawa k. J Infect Chemother. 2019 Nov;25(11):837-844. doi: 10.1016/j.jiac.2019.07.018. Epub 2019 Aug 17. J Infect Chemother. 2019. PMID: 31427200
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer.
Matsumoto Y, Sawa K, Fukui M, Oyanagi J, Izumi M, Ogawa K, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kimura T, Yamamoto N, Koh Y, Kawaguchi T. Matsumoto Y, et al. Among authors: sawa k. Cancer Sci. 2019 Oct;110(10):3244-3254. doi: 10.1111/cas.14156. Epub 2019 Aug 30. Cancer Sci. 2019. PMID: 31368625 Free PMC article.
Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan.
Ogawa K, Koh Y, Kaneda H, Izumi M, Matsumoto Y, Sawa K, Fukui M, Taniguchi Y, Yoshimoto N, Tamiya A, Ando M, Kubo A, Isa SI, Saka H, Matsumura A, Kawaguchi T. Ogawa K, et al. Among authors: sawa k. BMJ Open. 2020 Sep 9;10(9):e035615. doi: 10.1136/bmjopen-2019-035615. BMJ Open. 2020. PMID: 32907893 Free PMC article.
Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.
Matsumoto Y, Sawa K, Fukui M, Oyanagi J, Yoshimoto N, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kimura T, Yamamoto N, Hirata K, Koh Y, Kawaguchi T. Matsumoto Y, et al. Among authors: sawa k. Lung Cancer. 2020 Jan;139:80-88. doi: 10.1016/j.lungcan.2019.10.029. Epub 2019 Nov 2. Lung Cancer. 2020. PMID: 31751804
Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR.
Mitsuoka S, Kawaguchi T, Kubo A, Isa S, Asai K, Uji M, Watanabe T, Sawa K, Yoshimoto N, Oka T, Nakai T, Suzumura T, Tanaka H, Matsuura K, Kimura T, Yoshimura N, Kudoh S, Hirata K. Mitsuoka S, et al. Among authors: sawa k. Expert Opin Pharmacother. 2016;17(2):193-203. doi: 10.1517/14656566.2016.1109635. Epub 2016 Jan 18. Expert Opin Pharmacother. 2016. PMID: 26781399 Review.
83 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page